• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物相关性味觉障碍:一项系统评价。

Drug-related Dysgeusia: A Systematic Review.

作者信息

Mortazavi Hamed, Shafiei Shervin, Sadr Soroush, Safiaghdam Hannaneh

出版信息

Oral Health Prev Dent. 2018;16(6):499-507. doi: 10.3290/j.ohpd.a41655.

DOI:10.3290/j.ohpd.a41655
PMID:30574604
Abstract

PURPOSE

Dysgeusia is an unpleasant alteration in taste. It can affect the nutritional and psychological status and decrease the quality of life of patients. It may be caused by nerve injury, head and neck trauma or surgery, infections, radiotherapy and drugs, but certain aetiological factors have not yet been identified. Understanding dysgeusia as a drug side effect is important for practitioners. The aim of this systematic review was to provide detailed information about dysgeusia in patients receiving different common medications.

MATERIALS AND METHODS

An electronic search was conducted in MEDLINE, Google Scholar and Scopus databases, and studies were selected according to our inclusion criteria. We included studies on human subjects that reported dysgeusia as a drug side effect.

RESULTS

Thirty-four eligible studies were included in the systematic review. Thirty-five drugs were found in the literature to be correlated to dysgeusia. The most commonly reported offending drugs were from keratolytic agents, chemotherapeutic and cancer medication, antihistamine, antibiotics and angiotensin-converting enzyme inhibitors.

CONCLUSION

The quality of evidence was low in most reviewed studies. More studies with standard methodology are needed in this field. However, physicians and dental practitioners must consider the probability of dysgeusia as an adverse side effect when prescribing certain medications.

摘要

目的

味觉障碍是一种味觉的不良改变。它会影响患者的营养和心理状况,并降低其生活质量。其可能由神经损伤、头颈部创伤或手术、感染、放疗及药物引起,但某些病因尚未明确。对从业者而言,将味觉障碍理解为药物副作用很重要。本系统评价的目的是提供接受不同常用药物治疗的患者味觉障碍的详细信息。

材料与方法

在MEDLINE、谷歌学术和Scopus数据库中进行电子检索,并根据纳入标准选择研究。我们纳入了将味觉障碍报告为药物副作用的人体研究。

结果

34项符合条件的研究被纳入该系统评价。文献中发现35种药物与味觉障碍相关。最常报告的致病药物来自角质溶解剂、化疗和癌症用药、抗组胺药、抗生素及血管紧张素转换酶抑制剂。

结论

大多数纳入评价的研究证据质量较低。该领域需要更多采用标准方法的研究。然而,医生和牙科从业者在开具某些药物处方时必须考虑味觉障碍作为不良副作用的可能性。

相似文献

1
Drug-related Dysgeusia: A Systematic Review.药物相关性味觉障碍:一项系统评价。
Oral Health Prev Dent. 2018;16(6):499-507. doi: 10.3290/j.ohpd.a41655.
2
Oral adverse effects of drugs: Taste disorders.药物的口腔不良反应:味觉障碍。
Oral Dis. 2020 Jan;26(1):213-223. doi: 10.1111/odi.13199. Epub 2019 Nov 11.
3
The etiologies and considerations of dysgeusia: A review of literature.味觉障碍的病因和注意事项:文献回顾。
J Oral Biosci. 2021 Dec;63(4):319-326. doi: 10.1016/j.job.2021.08.006. Epub 2021 Sep 3.
4
If it is not cough, it must be dysgeusia: differing adverse effects of angiotensin-converting enzyme inhibitors in the same individual.
J Am Med Dir Assoc. 2004 Mar-Apr;5(2):107-10. doi: 10.1097/01.JAM.0000110651.94489.1A.
5
The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review.吞咽障碍、味觉障碍、口腔黏膜炎和口干症对头颈部癌症患者营养状况、口腔摄入和体重减轻的影响:系统评价。
Cancer Treat Rev. 2016 Apr;45:105-19. doi: 10.1016/j.ctrv.2016.03.006. Epub 2016 Mar 14.
6
Taste alteration and impact on quality of life after head and neck radiotherapy.头颈部放疗后味觉改变及其对生活质量的影响。
J Oral Pathol Med. 2013 Jan;42(1):106-12. doi: 10.1111/j.1600-0714.2012.01200.x. Epub 2012 Aug 3.
7
Evaluation of Chemotherapy-induced Dysgeusia in Patients With Gastrointestinal Cancer: A Pilot Study.胃肠道癌症患者化疗相关性味觉障碍的评估:一项初步研究。
In Vivo. 2023 Jul-Aug;37(4):1894-1900. doi: 10.21873/invivo.13283.
8
9
Non-pharmacological strategies to alleviate dysgeusia in patients undergoing chemotherapy: A systematic review.非药物策略缓解化疗患者味觉障碍的系统评价。
Eur J Oncol Nurs. 2024 Jun;70:102569. doi: 10.1016/j.ejon.2024.102569. Epub 2024 Mar 26.
10
Risk factors for dysgeusia during chemotherapy for solid tumors: a retrospective cross-sectional study.实体瘤化疗期间味觉障碍的危险因素:一项回顾性横断面研究。
Support Care Cancer. 2022 Jan;30(1):313-325. doi: 10.1007/s00520-021-06219-4. Epub 2021 Jul 20.

引用本文的文献

1
Does presbygeusia really exist? An updated narrative review.味觉衰老真的存在吗?一篇更新的叙述性综述。
Aging Clin Exp Res. 2024 Apr 1;36(1):84. doi: 10.1007/s40520-024-02739-1.
2
Palliative oral care in terminal cancer patients: Integrated review.晚期癌症患者的姑息性口腔护理:综合综述。
World J Clin Cases. 2023 May 6;11(13):2966-2980. doi: 10.12998/wjcc.v11.i13.2966.
3
[Mechanisms and Management of COVID-19-Associated Taste Disorders].[新型冠状病毒肺炎相关味觉障碍的机制与管理]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2023 Mar;54(2):334-341. doi: 10.12182/20230260306.
4
Endocrinology of Taste with Aging.味觉的内分泌变化与衰老
Endocrinol Metab Clin North Am. 2023 Jun;52(2):295-315. doi: 10.1016/j.ecl.2022.10.002. Epub 2023 Feb 16.
5
MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer.MASCC/ISOO 专家组关于晚期癌症患者口腔问题管理的专家意见。
Support Care Cancer. 2022 Nov;30(11):8761-8773. doi: 10.1007/s00520-022-07211-2. Epub 2022 Jun 18.
6
Evaluation of antibiotic-induced taste and smell disorders using the FDA adverse event reporting system database.使用 FDA 不良事件报告系统数据库评估抗生素引起的味觉和嗅觉障碍。
Sci Rep. 2021 May 5;11(1):9625. doi: 10.1038/s41598-021-88958-2.
7
Drug-related Halitosis: A Systematic Review.药物相关性口臭:一项系统评价
Oral Health Prev Dent. 2020 Jul 4;18(3):399-407. doi: 10.3290/j.ohpd.a44679.
8
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia.将恩杂鲁胺的服用时间从早晨改为夜间睡前可克服恩杂鲁胺引起的味觉障碍。
Case Rep Oncol. 2019 Aug 6;12(2):589-594. doi: 10.1159/000502054. eCollection 2019 May-Aug.
9
Oral adverse effects of drugs: Taste disorders.药物的口腔不良反应:味觉障碍。
Oral Dis. 2020 Jan;26(1):213-223. doi: 10.1111/odi.13199. Epub 2019 Nov 11.